| [1] |
LIAO C B, HUANG X, WANG Q X, et al. Virulence factors of Pseudomonas aeruginosa and antivirulence strategies to combat its drug resistance[J]. Frontiers in cellular and infection icrobioloy, 2022, 12:1-17.
|
| [2] |
CLARK S T, CABALLERO J D, CHEANG M, et al. Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis[J]. Sci. rep., 2015, 5:10932.
doi: 10.1038/srep10932
|
| [3] |
EL-FOULY M Z, SHARAF A M, SHAHIN A A M, et al. Biosynthesis of pyocyanin pigment by Pseudomonas aeruginosa[J]. Journal of radiation research and applied sciences, 2015, 8:36-48.
doi: 10.1016/j.jrras.2014.10.007
URL
|
| [4] |
DRENKARD E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms[J]. Microbes and infection, 2003, 5(13):1213-1219.
doi: 10.1016/j.micinf.2003.08.009
URL
|
| [5] |
MULCAHY L R, BURNS J L, LORY S, et al. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis[J]. Journal of bacteriology, 2010, 192(23):6191-6199.
doi: 10.1128/JB.01651-09
URL
|
| [6] |
BEHZADI P, BARÁTH Z, GAJDÁCS M. It’s not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa[J]. Antibiotics, 2021, 10(1):42.
doi: 10.3390/antibiotics10010042
URL
|
| [7] |
EDUARDOVICH I M, FURSOVA N K, POTAPOV V D. Pseudomonas aeruginosa efflux pump superfamily (review of literature)[J]. Klinicheskaia laboratornaia diagnostika, 2022, 67(1):53-58.
|
| [8] |
LI H, LUO Y F, WILLIAMS B J, et al. Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies[J]. International journal of medical microbiology, 2012, 302(2):63-68.
doi: 10.1016/j.ijmm.2011.10.001
URL
|
| [9] |
BELLIDO F, MARTIN N L, SIEHNEL R J, et al. Reevaluation, using intact cells, of the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability[J]. Journal of bacteriology, 1992, 174(16):5196-5203.
doi: 10.1128/jb.174.16.5196-5203.1992
URL
|
| [10] |
MACFARLANE E L, KWASNICKA A, OCHS M M, et al. PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance[J]. Molecular microbiology, 1999, 34(2):305-316.
doi: 10.1046/j.1365-2958.1999.01600.x
URL
|
| [11] |
SINDELDECKERAB D, STOODLEY P. The many antibiotic resistance and tolerance strategies of Pseudomonas aeruginosa[J]. Biofilm, 2021, 3:100056
doi: 10.1016/j.bioflm.2021.100056
URL
|
| [12] |
BERRAZEG M, JEANNOT K, NTSOGO ENGUENE V Y, et al. Mutations in beta-Lactamase AmpC increase resistance of Pseudomonas aeruginosa isolates to antipseudomonal cephalosporins[J]. Antimicrobial agents and chemotherapy, 2015, 59(10):6248-6255.
doi: 10.1128/AAC.00825-15
URL
|
| [13] |
POIREL L, DE LA ROSA, JMO NORDMANN P. Acquisition of extended-spectrum beta-lactamase GES-6 leading to resistance to ceftolozane-tazobactam combination in Pseudomonas aeruginosa[J]. Antimicrobial agents and chemotherapy, 2019, 63(1):e01809-18.
|
| [14] |
SID AHMED M A, KHAN F A, HADI H A, et al. Association of blaVIM-2, blaPDC-35, blaOXA-10, blaOXA-488 and blaVEB-9 β-lactamase genes with resistance to ceftazidime-avibactam and ceftolozane-tazobactam in multidrug-resistant Pseudomonas aeruginosa[J]. Antibiotics, 2022, 11(2):130.
doi: 10.3390/antibiotics11020130
URL
|
| [15] |
SECKO D. New mechanisms of antibiotic resistance[J]. Canadian medical association journal, 2006, 174(9):1249-1249.
doi: 10.1503/cmaj.060098
URL
|
| [16] |
FERNANDEZ L, HANCOCK R E. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance[J]. Clinical microbiology reviews, 2012, 25(4):661-681.
doi: 10.1128/CMR.00043-12
pmid: 23034325
|
| [17] |
FANG Z L, ZHANG L Y, HUANG Y M, et al. OprD mutations and inactivation in imipenem-resistant Pseudomonas aeruginosa isolates from China[J]. Infection genetics and evolution, 2014, 21:124-128.
doi: 10.1016/j.meegid.2013.10.027
URL
|
| [18] |
WOLTER D J, HANSON N D, LISTER P D. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance[J]. Fems microbiology letters, 2004, 236(1):137-143.
doi: 10.1111/fml.2004.236.issue-1
URL
|
| [19] |
HALL R M, COLLIS C M. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination[J]. Molecular microbiology, 1995, 15(4):593-600.
pmid: 7783631
|
| [20] |
CHEN J, SU Z, LIU Y, et al. Identification and characterization of class 1 integrons among Pseudomonas aeruginosa isolates from patients in Zhenjiang, China[J]. International journal of infectious diseases, 2009, 13(6):717-721.
doi: 10.1016/j.ijid.2008.11.014
URL
|
| [21] |
KHOSRAVI A D, MOTAHAR M, ABBASI MONTAZERI E. The frequency of class1 and 2 integrons in Pseudomonas aeruginosa strains isolated from burn patients in a burn center of Ahvaz, Iran[J]. Plos one, 2017, 12(8):e0183061.
|
| [22] |
SPERO M A, JEFF J, BRETT L, et al. Mechanisms of chlorate toxicity and resistance in Pseudomonas aeruginosa[J]. Molecular microbiology, 2022, 118(4):321-335.
doi: 10.1111/mmi.v118.4
URL
|
| [23] |
ODUMOSU B T, ADENIYI B A, CHANDRA R. Analysis of integrons and associated gene cassettes in clinical isolates of multidrug resistant Pseudomonas aeruginosa from Southwest Nigeria[J]. Annals of clinical microbiology and antimicrobials, 2013, 12(5):29-35.
doi: 10.1186/1476-0711-12-29
URL
|
| [24] |
YANG Q, LI Y, FANG L, et al. A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate[J]. Clinical microbiology and infection, 2022, 29(3):387.
|
| [25] |
YAEGER L N, COLES V E, CHAN D C, et al. How to kill Pseudomonas-emerging therapies for a challenging pathogen[J]. Ann. New York acad. sci, 2021, 1496(1):59-81.
doi: 10.1111/nyas.v1496.1
URL
|
| [26] |
THI M T T, WIBOWO D, REHM B H. Pseudomonas Aeruginosa biofilms[J]. Int. j. mol. sci., 2020, 21(22):8671.
doi: 10.3390/ijms21228671
URL
|
| [27] |
ABDULHAQ N, NAWAZ Z, ZAHOOR M A S, et al. Association of biofilm formation with multi drug resistance in clinical isolates of Pseudomonas aeruginosa[J]. Excli journal, 2020, 19:201-208.
|
), 王林, 秦上尚
